|
|
|
Corporate Profile: Esperance Pharmaceuticals
| Summary: |
Esperance Pharmaceuticals is focused on the research and development of cancer drugs called membrane disrupting peptides (MDPs).
|
| Address (HQ): |
Louisiana Emerging Technology Center
340 East Parker Boulevard
Baton Rouge, LA 70803
|
| Phone #'s (HQ): |
| Main |
(225) 615-8944 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax #'s (HQ): |
| Main |
(225) 615-8952 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Internet
job postings: |
| not known |
| Number
of employees: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications mentioning company on PubMed: publications
link. |
|
|
|
